Amir Nashat Insider Trading $SYRS Syros Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amir Nashat.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Amir Nashat. Amir Nashat is Director in aTYR PHARMA INC ($LIFE) and Director in BIND Therapeutics, Inc ($BIND) and Director in FATE THERAPEUTICS INC ($FATE) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Receptos, Inc. ($RCPT) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Metacrine, Inc. ($MTCR) and Director in Morphic Holding, Inc. ($MORF) and Director in Scholar Rock Holding Corp ($SRRK).
Amir Nashat in Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 1,164,486 shares
Current Value: $12,716,187
Latest Transaction: Jun 11 2020
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Amir Nashat in Syros Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LIFE, BIND, FATE, MTCR, MORF, RCPT, SRRK, SELB, SYRS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
| Jun 11 2020 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
| Jun 12 2019 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
| Jun 15 2018 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
| Jun 12 2017 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
| Sep 19 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | A | 12.59 | 22,000 | 276,980 | 22,000 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | C | 0.00 | 83,129 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | C | 0.00 | 4,366,825 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | P | 12.50 | 26,153 | 326,913 | 48,320 | 22.2 K to 48.3 K (+117.98 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | P | 12.50 | 373,847 | 4,673,088 | 1,538,333 | 1.2 M to 1.5 M (+32.10 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | C | 0.00 | 22,167 | 0 | 22,167 | 0 to 22.2 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | C | 0.00 | 1,164,486 | 0 | 1,164,486 | 0 to 1.2 M |
Page: 1